Mitochondrial coupling defect in Charcot–Marie–Tooth type 2A disease

Authors:
  • ACArnaud Chevrollier
    Arnaud Chevrollier
  • VGVirginie Guillet
    Virginie Guillet

Abstract
Objective: Mutations of the mitofusin 2 gene (MFN2) may account for at least a third of the cases of Charcot–Marie–Tooth disease type 2 (CMT2). This study investigates mitochondrial cellular bioenergetics in MFN2‐related CMT2A.Methods: Mitochondrial network morphology and metabolism were studied in cultures of skin fibroblasts obtained from four CMT2A patients harboring novel missense mutations of the MFN2 gene.Results: Although the mitochondrial network appeared morphologically unaltered, there was a significant defect of mitochondrial coupling associated with a reduction of the mitochondrial membrane potential.Interpretation: Our results suggest that the sharply reduced efficacy of oxidative phosphorylation in MFN2‐related CMT2A may contribute to the pathophysiology of the axonal neuropathy. Ann Neurol 2007;61:315–323

This publication has 50 references indexed in Scilit: